ORYZON GENOMICS S.A.

ORYZON GENOMICS S.A.

74,Carrer de Sant Ferran, 08940, Cornellà de Llobregat (Barcelona)

+34 934 037 196


More informations about "Oryzon Genomics S.a." on Search Engine

Home | Oryzon

May 07, 2021ย ยท ORYZON is a clinical stage biopharmaceutical company that leverages epigenetics to discover and develop innovative personalized therapeutics for patients with cancers and CNS disorders. We are able to identify and validate biomarkers and therapeutic targets through our epigenetic platform and translate them into advanced and personalized therapies.

Oryzon.com Go URL

Share Information | Oryzon

Jun 18, 2021ย ยท Oryzon Genomics, S.A. has created this section so that you may consult the information regarding your shares.

Oryzon.com Go URL

ORYZON GENOMICS, S.A. (ORY.MC) Company Profile & Facts ...

See the company profile for ORYZON GENOMICS, S.A. (ORY.MC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...

Finance.yahoo.com Go URL

Oryzon Genomics SA - Company Profile and News - Bloomberg ...

Oryzon Genomics SA. Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics. CURRENT PRICE. ORY:SM 3.55 EUR. -0.01 -0.14%.

Bloomberg.com Go URL

Other Relevant Information | Oryzon

The Other Relevant Information communications included in this section correspond exactly to those submitted to the Spanish securities market regulator (CNMV) and published on its website (www.cnmv.es). To consult all Oryzon Genomics, S.A. registered informationโ€ฆ

Oryzon.com Go URL

ORYZON GENOMICS, S.A. (ORY.MC) Stock Price, News, Quote ...

Find the latest ORYZON GENOMICS, S.A. (ORY.MC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com Go URL

Team | Oryzon

Oryzonโ€™s management team is composed of passionate biopharma executives exploring new fields of epigenetic science to transform it into innovative personalized medicines for patients.

Oryzon.com Go URL

Oryzon Genomics - Crunchbase Company Profile & Funding

Oryzon Genomics, S.A. is a clinical-stage biopharmaceutical company & the European leader in the development of epigenetics-based therapeutics, with strong focus on personalized medicine approaches to CNS disorders and oncology.

Crunchbase.com Go URL

ORYZON to Present New Clinical Data and Corporate Updates

May 13, 2021ย ยท ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in May and June. MADRID, Spain and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A ...

Globenewswire.com Go URL

ORYZON Initiates a New Project to Explore the Efficacy of ...

Jun 15, 2020ย ยท MADRID, Spain and CAMBRIDGE, Mass., June 15, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to ...

Markets.businessinsider.com Go URL

Oryzon Genomics S A : announces FDA approval of IND for ...

Jun 15, 2021ย ยท MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, June 15 th, 2021 - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received confirmation from the U.S. Food and Drug Administration (FDA) that its โ€ฆ

Marketscreener.com Go URL

ORYZON GENOMICS S.A. : All Information and News | ORY ...

All news about ORYZON GENOMICS S.A. 05/13: ORYZON GENOMICS S A : to present new clinical data and corporate updates at int.. PU

Marketscreener.com Go URL

ORYZON announces FDA approval of IND for PORTICO, a Phase

Jun 15, 2021ย ยท MADRID, Spain and CAMBRIDGE, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to ...

Globenewswire.com Go URL

Oryzon Genomics | AseBio

Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology. Our business model is to develop our proprietary drug candidates through clinical Phase II, at which point we decide on a case-by-case basis to either keep โ€ฆ

Asebio.com Go URL

Oryzon Genomics SA | LinkedIn

Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine ...

Linkedin.com Go URL

ORYZON to Present New Clinical Data and Corporate Updates ...

May 13, 2021ย ยท MADRID, Spain and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to ...

Finance.yahoo.com Go URL

Oryzon Genomics S A : to present new clinical data and ...

May 13, 2021ย ยท MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, May 13 th, 2021 - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it will present new clinical data and attend several renowned international conferences in โ€ฆ

Marketscreener.com Go URL

ORYN | Oryzon Genomics S.A. Profile | MarketWatch

Oryzon Genomics S.A. Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting ...

Marketwatch.com Go URL

Join Us | Oryzon

If you are interested in joining Oryzon Genomics, S.A., please complete the form available on this website by following the link below. Pursuant to the provisions of Regulation (EU) 2016/679 (GDPR), we advise you that the personal data you provide will be processed by Oryzon Genomics, S.A. for purposes of human resources management and staff selection.

Oryzon.com Go URL

ORYZON GENOMICS S.A. : Stock Market News and Information ...

ORYZON GENOMICS S.A. ORYZON GENOMICS S A : receives the INNOVATIVE SME seal from the Ministry of Sci.. ORYZON GENOMICS S A : starts preclinical collaboration on autism with the Seave.. ORYZON GENOMICS S A : enrolls first patient in PORTICO, a Phase IIb clinical tr..

Marketscreener.com Go URL